Smith & Nephew PLC SNNUF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $12.39
- Day Range
- $11.66–11.66
- 52-Week Range
- $10.80–16.74
- Bid/Ask
- $11.30 / $12.81
- Market Cap
- $10.19 Bil
- Volume/Avg
- 467 / 3,067
Key Statistics
- Price/Earnings (Normalized)
- 13.61
- Price/Sales
- 1.95
- Dividend Yield (Trailing)
- 3.22%
- Dividend Yield (Forward)
- 3.22%
- Total Yield
- 3.22%
Company Profile
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 41% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Mid Core
- Total Number of Employees
- 18,452
- Website
- https://www.smith-nephew.com
Competitors
Valuation
|
Metric
|
SNNUF
|
SYK
|
ZBH
|
|---|---|---|---|
Price/Earnings (Normalized) | 13.61 | 30.91 | 16.03 |
Price/Book Value | 2.08 | 6.70 | 2.00 |
Price/Sales | 1.95 | 6.13 | 3.44 |
Price/Cash Flow | 11.51 | 29.86 | 12.85 |
Price/Earnings
SNNUF
SYK
ZBH
Financial Strength
|
Metric
|
SNNUF
|
SYK
|
ZBH
|
|---|---|---|---|
Quick Ratio | 0.67 | 0.86 | 0.65 |
Current Ratio | 1.77 | 1.58 | 1.61 |
Interest Coverage | 2.84 | 11.32 | 6.30 |
Quick Ratio
SNNUF
SYK
ZBH
Profitability
|
Metric
|
SNNUF
|
SYK
|
ZBH
|
|---|---|---|---|
Return on Assets (Normalized) | 7.27% | 10.75% | 7.45% |
Return on Equity (Normalized) | 13.79% | 23.27% | 12.87% |
Return on Invested Capital (Normalized) | 9.92% | 14.37% | 9.78% |
Return on Assets
SNNUF
SYK
ZBH
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Gxvyxfk | Jmrymqg | $185.4 Bil | |
SYK
| Stryker Corp | Wqflptlvb | Hms | $128.2 Bil | |
BSX
| Boston Scientific Corp | Zbgctnvf | Kmfznvn | $107.7 Bil | |
MDT
| Medtronic PLC | Wglvzztvd | Mkxdp | $105.2 Bil | |
DXCM
| DexCom Inc | Wrnswphm | Mjfkp | $54.7 Bil | |
EW
| Edwards Lifesciences Corp | Xyhjjkhw | Fnqfqx | $52.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Qqlzrxvnfz | Rvhjy | $24.9 Bil | |
ALGN
| Align Technology Inc | Jsqlcbn | Tbbxb | $23.5 Bil | |
PHG
| Koninklijke Philips NV ADR | Rrkpvrmbc | Xklylz | $18.9 Bil | |
PODD
| Insulet Corp | Nksfmfmwj | Vssnvdg | $11.7 Bil |